Prescription pricing authority aims to promote high quality prescribing

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6974.254a (Published 28 January 1995) Cite this as: BMJ 1995;310:254
  1. John Ferguson*,
  2. C M Harris*,
  3. G England*,
  4. N Hough*,
  5. M G Lee,
  6. D Archer*,
  7. T Ewington*,
  8. P Clappison*
  1. Medical director Prescriptions Pricing Authority, Newcastle upon Tyne NE1 6SN
  2. Director Prescribing Research Unit, University of Leeds, Leeds LS2 9NZ
  3. Director Medical Advisers' Support Centre, Liverpool L3 6AL
  4. Director Medicines Resource Centre, Liverpool L3 6AL
  5. Regional quality control pharmacist North West Regional Health Authority, Liverpool L3 6AL
  6. Director Management Services Information Systems Development Unit, Stockport SK1 3SH
  7. Senior principal Senior medical officer NHS Executive, Leeds LS2 7UE

    EDITOR,—Dermot Ryan and Mark Levy, in their letter about the reports sent by the Prescription Pricing Authority, make three main comments about the centre page report on asthma sent to all general practitioners in England in August 1994.2

    The Prescribing Research Unit and the General Practitioners in Asthma Group, of which Ryan and Levy are members, jointly undertook the research on which the comment from the Prescribing Research Unit was based. It would not have been appropriate to cite the level …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription